Correlation between relative number of circulating low-density hepatitis C virus particles and disease activity in patients with chronic hepatitis C

Digestive Diseases and Sciences

Volumn 42, Issue 12, 1997, Pages 2476-2481

  Hino, Keisuke ^a   Fujii, Kaori ^a   Korenaga, Masaaki ^a   Murakami, Chisa ^a   Okazaki, Muneko ^a   Okuda, Michiari ^a   Okita, Kiwamu ^a  

^a YAMAGUCHI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Buoyant density; Chronic hepatitis C; Hepatitis C virus

Indexed keywords

ALANINE AMINOTRANSFERASE;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANTIGEN ANTIBODY COMPLEX; ARTICLE; CHRONIC HEPATITIS; CLINICAL ARTICLE; DENSITY GRADIENT CENTRIFUGATION; DISEASE ACTIVITY; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNOPRECIPITATION; MALE; PRIORITY JOURNAL; VIRUS PARTICLE; VIRUS TITRATION;

ADULT; ALANINE TRANSAMINASE; CENTRIFUGATION; DISEASE PROGRESSION; FEMALE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; PRECIPITIN TESTS; RNA, VIRAL;

EID: 0031408950     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1018800225815     Document Type: Article

References (18)

1. Bradley DW, McCaustrand KA, Spelbring J, Cook EH: Hepatitis C virus: Buoyant density of the factor VIII-derived isolate in sucrose. J Med Virol 34:206-208, 1991
2. Hijikata M, Shimizu YK, Kato H, Iwamoto A, Shin JW, Alter HJ, Purcell RH, Yoshikura H: Equilibrium centrifugation studies of hepatitis C virus: Evidence for circulating immune complexes. J Virol 67:1953-1958, 1993
3. Miyamoto H, Okamoto H, Sato K, Tanaka T, Mishiro S: Extraordinarily low density of hepatitis C virus estimated by sucrose density gradient centrifugation and the polymerase chain reaction. J Gen Virol 73:715-718, 1992
4. Kanto T, Hayashi N, Takehara T, Hagiwara H, Mita E, Naito M, Kasahara A, Fusamoto H, Kamada T: Buoyant density of hepatitis C virus recovered from infected hosts: Two different features in sucrose equilibrium density-gradient centrifugation related to degree of liver inflammation. Hepatology 19:296-302, 1994
5. Kanto T, Hayashi N, Takehara T, Hagiwara H, Mita E, Naito M, Kasahara A, Fusamoto H, Kamada T: Density analysis of hepatitis C virus particle population in the circulation of infected hosts: Implication for virus neutralization or persistence. J Hepatol 22:440-448, 1995
6. Kanto T, Hayashi N, Takehara T, Hagiwara H, Mita E, Oshita M, Katayama K, Kasahara A, Fusamoto H, Kamada T: Serial density analysis of hepatitis C virus particle population in chronic hepatitis C patients treated with interferon-α. J Med Virol 46:230-237, 1995
7. Thomssen R, Bonk S, Propfe C, Heermann KH, Kochel HG, Uy A: Association of hepatitis C virus in human sera with β-lipoprotein. Med Microbiol Immunol 181:293-300, 1992
8. Shimizu YK, Hijikata M, Iwamoto A, Alter HJ, Purcell RH, Yoshikura H: Neutralizing antibodies against hepatitis C virus and the emergence of neutralization escape mutant viruses. J Virol 68:1494-1500, 1994
9. Desmet VJ, Gerber M, Hoofnagle JH, Manns M, Scheuer PJ: Classification of chronic hepatitis: Diagnosis, grading and staging. Hepatology 19:1513-1520, 1994
10. Simmonds P, Holmes EC, Cha TA, Chan SW, McOmish F, Irvine B, Beall E, Yap PL, Kolberg J, Urdea MS: Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region. J Gen Virol 74:2391-2399, 1993
11. Hatch FT, Lees RS: Practical methods for plasma lipoprotein analysis: Preparative ultracentrifugation. In Advances in Lipid Research, Vol 6. R Paoletti, D Kritchevsky (eds). New York, Academic Press, 1968, pp 33-36
12. Okamoto H, Okada S, Sugiyama Y, Tanaka T, Sugai Y, Akahane Y, Machida A, Mishiro S, Yashizawa H, Miyakawa Y, Mayumi M: Detection of hepatitis C virus RNA by a two-stage polymerase chain reaction with two pairs of primers deduced from the 5′-noncoding region. Jpn J Exp Med 60:215-222, 1990
13. Fujii K, Hino K, Okazaki M, Okuda M, Kondoh S, Okita K: Differences in hypervariable region 1 quasispesies of hepatitis C virus between human serum and peripheral blood mononuclear cells. Biochem Biophys Res Commun 225:771-776, 1996
14. Okamoto H, Sugiyama Y, Okada S, Kurai K, Akahane Y, Sugai Y, Tanaka T, Sato K, Tsuda F, Miyakawa Y, Mayumi M: Typing hepatitis C virus by polymerase chain reaction with type-specific primers: Application to clinical surveys and tracing infectious sources. J Gen Virol 73:673-679, 1992
15. Hino K, Okuda M, Konishi T, Ishiko H, Okita K: Serial assay of hepatitis C virus RNA in serum for predicting response to interferon-α therapy. Dig Dis Sci 40:14-20, 1995
16. Ghany MG, Chan TM, Sanchez-Pescador R, Urdea M, Lok ASF: Correlation between serum HCV RNA and aminotransferase levels in patients with chronic HCV infection. Dig Dis Sci 41:2213-2218, 1996
17. Ariyama T, Yoshioka K, Okumura A, Takayanagi M, Iwata K, Ishikawa T, Kakumu S: Sequence analysis of hypervariable region of hepatitis C virus (HCV) associated with immune complex in patients with chronic HCV infection. J Infect Dis 174:1316-1320, 1996
18. Kato N, Ootsuyama Y, Sekiya H, Ohkoshi S, Nakazawa T, Hijikata M, Shimotohno K: Genetic drift in hypervariable region 1 of the viral genome in persistent hepatitis C virus infection. J Virol 68:4776-4784, 1994